Ribociclib-induced phototoxicity - the era of new drugs and new toxicities
Introduction. Ribociclib belongs to the family of cyclin-dependent kinases 4/6 inhibitors and it has been approved in 2017 for the treatment of patients with hormone receptor-positive (ER+) and human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer. As a drug that has been...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Serbian Medical Society
2024-01-01
|
| Series: | Srpski Arhiv za Celokupno Lekarstvo |
| Subjects: | |
| Online Access: | https://doiserbia.nb.rs/img/doi/0370-8179/2024/0370-81792400092B.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|